Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 41

Sort by

Sort Order Select

Journal Articles

The Impact of Pre-Apheresis Health Related Quality of Life on Peripheral Blood Progenitor Cell Yield and Donor's Health and Outcome: Secondary Analysis of Rdsafe and BMT CTN 0201

Nosha Farhadfar, Stephanie Bo-Subait, Kwang Woo Ahn, Brent R. Logan, Heather E. Stefanski, Jack W. Hsu, Sandhya R. Panch, Dennis L. Confer, Claudio Anasetti, Michael A. Pulsipher, Bronwen E. Shaw, John R. Wingard, Galen E. Switzer

Blood (2021) 138 (Supplement 1): 1772.

https://doi.org/10.1182/blood-2021-151034

Published: 2021

Journal Articles

Bridging the Gap in Access to Transplant for Underserved Minority Patients Using Mismatched Unrelated Donors and Post-Transplant Cyclophosphamide: A National Marrow Donor Program/be the Match (NMDP/BTM) Initiative

Blood (2020) 136 (Supplement 1): 48–49.

https://doi.org/10.1182/blood-2020-137677

Published: 2020

Journal Articles

Selection of unrelated donors and cord blood units for hematopoietic cell transplantation: guidelines from the NMDP/CIBMTR

Jason Dehn, Stephen Spellman, Carolyn K. Hurley, Bronwen E. Shaw, Juliet N. Barker, Linda J. Burns, Dennis L. Confer, Mary Eapen, Marcelo Fernandez-Vina, Robert Hartzman, Martin Maiers, Susana R. Marino, Carlheinz Mueller, Miguel-Angel Perales, Raja Rajalingam, Joseph Pidala

Blood (2019) 134 (12): 924–934.

https://doi.org/10.1182/blood.2019001212

Published: 2019

Journal Articles

Weighty Choices: Selecting Optimal G-CSF Doses for Stem Cell Mobilization to Optimize Yield

Nosha Farhadfar, MD, Jack W. Hsu, MD, Brent R. Logan, PhD, Jennifer A. Sees, MPH, Pintip Chitphakdithai, PhD, Dennis L. Confer, MD, Michael A. Pulsipher, MD, Nirali N. Shah, MD, Galen E. Switzer, PhD, Bronwen E. Shaw, MD PhD, John R. Wingard, MD

Blood (2018) 132 (Supplement 1): 193.

https://doi.org/10.1182/blood-2018-193

Published: 2018

Journal Articles

Bone Marrow Transplant Product Quality Has Decreased Over Time— a Retrospective Examination of NMDP Collected Bone Marrow Products from 1994-2016

Nicole L. Prokopishyn, PhD, Deidre M. Kiefer, MPH, Michael A Pulsipher, MD, Galen E. Switzer, PhD, Nirali N Shah, MD, Paul V. O'Donnell, MD PhD, Brent R. Logan, PhD, Dennis L. Confer, MD, Bronwen E. Shaw, PhD MRCP, FRCPath

Blood (2017) 130 (Supplement 1): 1921.

https://doi.org/10.1182/blood.V130.Suppl_1.1921.1921

Published: 2017

Journal Articles

Feasibility of Allogeneic Hematopoietic Cell Transplantation Among High-Risk AML Patients in First Complete Remission: Results of the Transplant Objective from the SWOG (S1203) Randomized Phase III Study of Induction Therapy Using Standard 7+3 Therapy or Idarubicin with High-Dose Cytarabine (IA) Versus IA Plus Vorinostat

Blood (2016) 128 (22): 1166.

https://doi.org/10.1182/blood.V128.22.1166.1166

Published: 2016

Journal Articles

Pain, Symptoms, AEs, and Recovery after Second Unrelated Donor Collection of Marrow/Peripheral Blood Stem Cells Are Similar to Those of the First Donation

David Stroncek, MD, Bronwen E. Shaw, MBChB, PhD MRCP, MRCPath, Brent Logan, PhD, Deidre Marie Kiefer, MPH, Pintip Chitphakdithai, PhD, Galen E. Switzer, PhD, Nirali N Shah, MD, John P. Miller, MD PhD, Dennis L. Confer, MD, Michael A Pulsipher, MD

Blood (2016) 128 (22): 2177.

https://doi.org/10.1182/blood.V128.22.2177.2177

Published: 2016

Journal Articles

The effect of donor characteristics on survival after unrelated donor transplantation for hematologic malignancy

Blood (2016) 127 (2): 260–267.

https://doi.org/10.1182/blood-2015-08-663823

Published: 2016

Journal Articles

5 Year Results of BMT CTN 0201: Unrelated Donor Bone Marrow Is Associated with Better Psychological Well-Being and Less Burdensome Chronic Gvhd Symptoms Than Peripheral Blood

Stephanie J. Lee, MD MPH, Brent Logan, PhD, Peter Westervelt, MD PhD, Corey S Cutler, MD MPH, Ann E Woolfrey, MD, Shakila Khan, MD, Edmund K Waller, MD PhD, Richard T. Maziarz, MD, Juan Wu, Bronwen E. Shaw, MBChB, PhD MRCP, MRCPath, Dennis L. Confer, MD, Mary M. Horowitz, MD MS, Claudio Anasetti, MD

Blood (2015) 126 (23): 270.

https://doi.org/10.1182/blood.V126.23.270.270

Published: 2015

Journal Articles

Outcome of Patients 65 Years and Older with Myelodysplastic Syndrome (MDS) Receiving Allogeneic Hematopoietic Stem Cell Transplantation Compared to Patients 55-64 Years of Age

Ehab Atallah, MD, Mary M. Horowitz, MD MS, Brent Logan, PhD, Min Chen, MS, Michael J. Boo, JD, Corey S Cutler, MD MPH, Joachim Deeg, MD, James L. Gajewski, MD, Dennis L. Confer, MD, Stephanie Farnia, MPH, Peter Greenberg, MD, Erica Warlick, MD, Daniel Weisdorf, MD, J. Douglas Rizzo, MD

Blood (2015) 126 (23): 193.

https://doi.org/10.1182/blood.V126.23.193.193

Published: 2015

Journal Articles

Alemtuzumab-Cyclosporine Versus Tacrolimus-Methotrexate-Sirolimus for Graft-Versus-Host Disease Prophylaxis in Reduced Intensity Allogeneic Hematopoietic Stem Cell Transplantation from Unrelated Donors: Final Results of a Randomized Trial

Blood (2015) 126 (23): 65.

https://doi.org/10.1182/blood.V126.23.65.65

Published: 2015

Journal Articles

Baseline Symptoms, Female Sex, and Younger Age Are Correlated with Higher Levels of Peri-Collection Pain, Symptoms, and Persistent Discomfort One Year after Related Donor BM and PBSC Donation: An Analysis of the Related Donor Safety Study (RDSafe)

Michael A. Pulsipher, MD, Brent R. Logan, PhD, Deidre M. Kiefer, MPH, Pintip Chitphakdithai, PhD, Galen E. Switzer, PhD, Marcie L Riches, MD MS, J. Douglas Rizzo, MD, Paolo Anderlini, MD, Susan F. Leitman, James W Varni, PhD, Amy Hays, MPH, RN, Hati Kobusingye, MS, RaeAnne M. Besser, John P. Miller, MD PhD, Rebecca J. Drexler, BS, Roberta J. King, MPH, Mary M. Horowitz, MD MS, Willis H. Navarro, MD, Dennis L. Confer, MD

Blood (2014) 124 (21): 3847.

https://doi.org/10.1182/blood.V124.21.3847.3847

Published: 2014

Journal Articles

Optimized Cyclophosphamide (CY) Dosing in Combination with Fludarabine, TBI and ATG As Conditioning for Unrelated Donor Bone Marrow Transplantation (BMT) in Severe Aplastic Anemia (SAA): A Phase I/II Study from the Blood and Marrow Transplant Clinical Trials Network (BMT CTN)

Paolo Anderlini, MD, Juan Wu, MS, H. Joachim Deeg, MD, Iris Gersten, MS, Marian Ewell, ScD, Jakub Tolar, MD PhD, Joseph H. Antin, MD, Sally Arai, MD, Mitchell E. Horwitz, MD, John M. McCarty, MD, Ryotaro Nakamura, MD, Michael A. Pulsipher, MD, Roberta H. Adams, MD, Eric Leifer, PhD, Shelly L Carter, ScD, Nancy L DiFronzo, PhD, Mary M. Horowitz, MD MS, Dennis L. Confer, MD, Mary Eapen, MBBS, MS

Blood (2014) 124 (21): 541.

https://doi.org/10.1182/blood.V124.21.541.541

Published: 2014

Journal Articles

Lower risk for serious adverse events and no increased risk for cancer after PBSC vs BM donation

Michael A. Pulsipher, Pintip Chitphakdithai, Brent R. Logan, Willis H. Navarro, John E. Levine, John P. Miller, Bronwen E. Shaw, Paul V. O’Donnell, Navneet S. Majhail, Dennis L. Confer

Blood (2014) 123 (23): 3655–3663.

https://doi.org/10.1182/blood-2013-12-542464

Published: 2014

Includes: Supplemental data

Journal Articles

7/8 High-Resolution Unrelated Donor HLA Match Rate: Caucasian, African American, Hispanic, and Asian-Pacific Islander

Kelly Buck, MT(ASCP), Jason Dehn, MPH, CHTC, Michelle Setterholm, Martin Maiers, Dennis L. Confer, MD, Robert J Hartzman, MD, Kim Wadsworth, Ph.D., Soo Young Yang, PhD, Alexander H. Schmidt

Blood (2013) 122 (21): 1998.

https://doi.org/10.1182/blood.V122.21.1998.1998

Published: 2013

Journal Articles

Global Hematopoietic Stem Cell Transplantation (HSCT) At One Million: An Achievement Of Pioneers and Foreseeable Challenges For The Next Decade. A Report From The Worldwide Network For Blood and Marrow Transplantation (WBMT)

Blood (2013) 122 (21): 2133.

https://doi.org/10.1182/blood.V122.21.2133.2133

Published: 2013

Journal Articles

Influence Of Race and Ethnicity On The Collection Of G-CSF Mobilized Peripheral Blood Stem Cells From Unrelated Donors, a Center For International Blood and Marrow Transplant Research Analysis

Jack W. Hsu, MD, John R. Wingard, MD, PhD, Brent R. Logan, PhD, Pintip Chitphakdithai, PhD, Bronwen E. Shaw, MBChB, MRCP, PhD, FRCPath, Steven C. Goldstein, MD, Paul V. O’Donnell, MD, PhD, FACP, Dennis L. Confer, MD

Blood (2013) 122 (21): 3273.

https://doi.org/10.1182/blood.V122.21.3273.3273

Published: 2013

Journal Articles

Multiple mismatches at the low expression HLA loci DP, DQ, and DRB3/4/5 associate with adverse outcomes in hematopoietic stem cell transplantation

Marcelo A. Fernández-Viña, John P. Klein, Michael Haagenson, Stephen R. Spellman, Claudio Anasetti, Harriet Noreen, Lee Ann Baxter-Lowe, Pedro Cano, Neal Flomenberg, Dennis L. Confer, Mary M. Horowitz, Machteld Oudshoorn, Effie W. Petersdorf, Michelle Setterholm, Richard Champlin, Stephanie J. Lee, Marcos de Lima

Blood (2013) 121 (22): 4603–4610.

https://doi.org/10.1182/blood-2013-02-481945

Published: 2013

Includes: Supplemental data

Journal Articles

Race and ethnicity in decisions about unrelated hematopoietic stem cell donation

Galen E. Switzer, Jessica G. Bruce, Larissa Myaskovsky, Andrea DiMartini, Diana Shellmer, Dennis L. Confer, Linda K. Abress, Roberta J. King, Allyson G. Harnaha, Sibylle Ohngemach, Mary Amanda Dew

Blood (2013) 121 (8): 1469–1476.

https://doi.org/10.1182/blood-2012-06-437343

Published: 2013

Journal Articles

Acute toxicities of unrelated bone marrow versus peripheral blood stem cell donation: results of a prospective trial from the National Marrow Donor Program

Blood (2013) 121 (1): 197–206.

https://doi.org/10.1182/blood-2012-03-417667

Published: 2013

Includes: Supplemental data

NARROW

The Impact of Pre-Apheresis Health Related Quality of Life on Peripheral Blood Progenitor Cell Yield and Donor's Health and Outcome: Secondary Analysis of Rdsafe and BMT CTN 0201

Bridging the Gap in Access to Transplant for Underserved Minority Patients Using Mismatched Unrelated Donors and Post-Transplant Cyclophosphamide: A National Marrow Donor Program/be the Match (NMDP/BTM) Initiative

Selection of unrelated donors and cord blood units for hematopoietic cell transplantation: guidelines from the NMDP/CIBMTR

Weighty Choices: Selecting Optimal G-CSF Doses for Stem Cell Mobilization to Optimize Yield

Bone Marrow Transplant Product Quality Has Decreased Over Time— a Retrospective Examination of NMDP Collected Bone Marrow Products from 1994-2016

Pain, Symptoms, AEs, and Recovery after Second Unrelated Donor Collection of Marrow/Peripheral Blood Stem Cells Are Similar to Those of the First Donation

The effect of donor characteristics on survival after unrelated donor transplantation for hematologic malignancy

5 Year Results of BMT CTN 0201: Unrelated Donor Bone Marrow Is Associated with Better Psychological Well-Being and Less Burdensome Chronic Gvhd Symptoms Than Peripheral Blood

Outcome of Patients 65 Years and Older with Myelodysplastic Syndrome (MDS) Receiving Allogeneic Hematopoietic Stem Cell Transplantation Compared to Patients 55-64 Years of Age

Alemtuzumab-Cyclosporine Versus Tacrolimus-Methotrexate-Sirolimus for Graft-Versus-Host Disease Prophylaxis in Reduced Intensity Allogeneic Hematopoietic Stem Cell Transplantation from Unrelated Donors: Final Results of a Randomized Trial

Baseline Symptoms, Female Sex, and Younger Age Are Correlated with Higher Levels of Peri-Collection Pain, Symptoms, and Persistent Discomfort One Year after Related Donor BM and PBSC Donation: An Analysis of the Related Donor Safety Study (RDSafe)

Optimized Cyclophosphamide (CY) Dosing in Combination with Fludarabine, TBI and ATG As Conditioning for Unrelated Donor Bone Marrow Transplantation (BMT) in Severe Aplastic Anemia (SAA): A Phase I/II Study from the Blood and Marrow Transplant Clinical Trials Network (BMT CTN)

Lower risk for serious adverse events and no increased risk for cancer after PBSC vs BM donation

7/8 High-Resolution Unrelated Donor HLA Match Rate: Caucasian, African American, Hispanic, and Asian-Pacific Islander

Global Hematopoietic Stem Cell Transplantation (HSCT) At One Million: An Achievement Of Pioneers and Foreseeable Challenges For The Next Decade. A Report From The Worldwide Network For Blood and Marrow Transplantation (WBMT)

Influence Of Race and Ethnicity On The Collection Of G-CSF Mobilized Peripheral Blood Stem Cells From Unrelated Donors, a Center For International Blood and Marrow Transplant Research Analysis

Multiple mismatches at the low expression HLA loci DP, DQ, and DRB3/4/5 associate with adverse outcomes in hematopoietic stem cell transplantation

Race and ethnicity in decisions about unrelated hematopoietic stem cell donation

Acute toxicities of unrelated bone marrow versus peripheral blood stem cell donation: results of a prospective trial from the National Marrow Donor Program

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only